Immunogenetics of rheumatoid arthritis: Understanding functional implications

Journal of Autoimmunity

Volumn 64, Issue , 2015, Pages 74-81

  Messemaker, Tobias C ^a   Huizinga, Tom W ^a   Kurreeman, Fina ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Autoimmunity; Genetics; GWAS; Non coding RNA; Rheumatoid arthritis

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; JANUS KINASE; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; STAT PROTEIN; T LYMPHOCYTE RECEPTOR; UNTRANSLATED RNA; HLA ANTIGEN;

ALLELE; DISEASE ASSOCIATION; ENHANCER REGION; GENE; GENE EXPRESSION; GENE LOCUS; GENETIC RISK; GENETIC VARIABILITY; HLA SYSTEM; HUMAN; IMMUNOGENETICS; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; ANIMAL; AUTOIMMUNITY; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; IMMUNOLOGY; METABOLISM; REGULATORY SEQUENCE;

ANIMALS; ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HLA ANTIGENS; HUMANS; IMMUNOGENETICS; REGULATORY SEQUENCES, NUCLEIC ACID; RNA, UNTRANSLATED; SIGNAL TRANSDUCTION;

EID: 84946486800     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2015.07.007     Document Type: Review

References (118)

1. Hoy D.G., Smith E., Cross M., Sanchez-Riera L., Blyth F.M., Buchbinder R., et al. Reflecting on the global burden of musculoskeletal conditions: lessons learnt from the global burden of disease 2010 study and the next steps forward. Ann. Rheum. Dis. 2015 Jan, 74(1):4-7.
2. Rudan I., Sidhu S., Papana A., Meng S.J., Xin-Wei Y., Wang W., et al. Prevalence of rheumatoid arthritis in low- and middle-income countries: A systematic review and analysis. J. Glob. Health 2015 Jun, 5(1):010409.
3. McInnes I.B., Schett G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 2011 Dec 8, 365(23):2205-2219.
4. Willemze A., Trouw L.A., Toes R.E., Huizinga T.W. The influence of ACPA status and characteristics on the course of RA. Nat. Rev. Rheumatol. 2012 Mar, 8(3):144-152.
5. Machold K.P., Stamm T.A., Nell V.P., Pflugbeil S., Aletaha D., Steiner G., et al. Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease. Rheumatol. Oxf. 2007 Feb, 46(2):342-349.
6. MacGregor A.J., Snieder H., Rigby A.S., Koskenvuo M., Kaprio J., Aho K., et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum. 2000 Jan, 43(1):30-37.
7. Silman A.J., MacGregor A.J., Thomson W., Holligan S., Carthy D., Farhan A., et al. Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br. J. Rheumatol. 1993 Oct, 32(10):903-907.
8. van der Woude D., Houwing-Duistermaat J.J., Toes R.E., Huizinga T.W., Thomson W., Worthington J., et al. Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis. Arthritis Rheum. 2009 Apr, 60(4):916-923.
9. Okada Y., Wu D., Trynka G., Raj T., Terao C., Ikari K., et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 2014 Feb 20, 506(7488):376-381.
10. Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N. Engl. J. Med. 1978 Apr 20, 298(16):869-871.
11. Gregersen P.K., Silver J., Winchester R.J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987 Nov, 30(11):1205-1213.
12. Raychaudhuri S., Sandor C., Stahl E.A., Freudenberg J., Lee H.S., Jia X., et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat. Genet. 2012 Mar, 44(3):291-296.
13. Reynolds R.J., Ahmed A.F., Danila M.I., Hughes L.B., Gregersen P.K., Raychaudhuri S., et al. HLA-DRB1-associated rheumatoid arthritis risk at multiple levels in African Americans: hierarchical classification systems, amino acid positions, and residues. Arthritis Rheumatol. 2014 Dec, 66(12):3274-3282.
14. Han B., Diogo D., Eyre S., Kallberg H., Zhernakova A., Bowes J., et al. Fine mapping seronegative and seropositive rheumatoid arthritis to shared and distinct HLA alleles by adjusting for the effects of heterogeneity. Am. J. Hum. Genet. 2014 Apr 3, 94(4):522-532.
15. Irigoyen P., Lee A.T., Wener M.H., Li W., Kern M., Batliwalla F., et al. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles. Arthritis Rheum. 2005 Dec, 52(12):3813-3818.
16. Verpoort K.N., van Gaalen F.A., van der Helm-van Mil A.H., Schreuder G.M., Breedveld F.C., Huizinga T.W., et al. Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis. Arthritis Rheum. 2005 Oct, 52(10):3058-3062.
17. Oka S., Furukawa H., Kawasaki A., Shimada K., Sugii S., Hashimoto A., et al. Protective effect of the HLA-DRB1*13:02 allele in Japanese rheumatoid arthritis patients. PLoS One 2014, 9(6):e99453.
18. van der Woude D., Lie B.A., Lundstrom E., Balsa A., Feitsma A.L., Houwing-Duistermaat J.J., et al. Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in four European populations. Arthritis Rheum. 2010 May, 62(5):1236-1245.
19. van H.J., Jansen D.T., Polydorides S., Moustakas A.K., Bax M., Feitsma A.L., et al. Crossreactivity to vinculin and microbes provides a molecular basis for HLA-based protection against rheumatoid arthritis. Nat. Commun. 2015, 6:6681.
20. Feitsma A.L., Worthington J., van der Helm-van Mil A.H., Plant D., Thomson W., Ursum J., et al. Protective effect of noninherited maternal HLA-DR antigens on rheumatoid arthritis development. Proc. Natl. Acad. Sci. U. S. A. 2007 Dec 11, 104(50):19966-19970.
21. Finishing the euchromatic sequence of the human genome. Nature 2004 Oct 21, 431(7011):931-945.
22. A haplotype map of the human genome. Nature 2005 Oct 27, 437(7063):1299-1320.
23. The International HapMap Project. Nature 2003 Dec 18, 426(6968):789-796.
24. Abecasis G.R., Auton A., Brooks L.D., DePristo M.A., Durbin R.M., Handsaker R.E., et al. An integrated map of genetic variation from 1,092 human genomes. Nature 2012 Nov 1, 491(7422):56-65.
25. Howie B., Marchini J., Stephens M. Genotype imputation with thousands of genomes. G3 (Bethesda) 2011 Nov, 1(6):457-470.
26. Eyre S., Bowes J., Diogo D., Lee A., Barton A., Martin P., et al. High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat. Genet. 2012 Dec, 44(12):1336-1340.
27. Liao K.P., Kurreeman F., Li G., Duclos G., Murphy S., Guzman R., et al. Associations of autoantibodies, autoimmune risk alleles, and clinical diagnoses from the electronic medical records in rheumatoid arthritis cases and non-rheumatoid arthritis controls. Arthritis Rheum. 2013 Mar, 65(3):571-581.
28. Okada Y., Terao C., Ikari K., Kochi Y., Ohmura K., Suzuki A., et al. Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population. Nat. Genet. 2012 May, 44(5):511-516.
29. Chen R., Stahl E.A., Kurreeman F.A., Gregersen P.K., Siminovitch K.A., Worthington J., et al. Fine mapping the TAGAP risk locus in rheumatoid arthritis. Genes Immun. 2011 Jun, 12(4):314-318.
30. Zhernakova A., Stahl E.A., Trynka G., Raychaudhuri S., Festen E.A., Franke L., et al. Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci. PLoS Genet. 2011 Feb, 7(2):e1002004.
31. Kurreeman F., Liao K., Chibnik L., Hickey B., Stahl E., Gainer V., et al. Genetic basis of autoantibody positive and negative rheumatoid arthritis risk in a multi-ethnic cohort derived from electronic health records. Am. J. Hum. Genet. 2011 Jan 7, 88(1):57-69.
32. Stahl E.A., Raychaudhuri S., Remmers E.F., Xie G., Eyre S., Thomson B.P., et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat. Genet. 2010 Jun, 42(6):508-514.
33. Raychaudhuri S., Thomson B.P., Remmers E.F., Eyre S., Hinks A., Guiducci C., et al. Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Nat. Genet. 2009 Dec, 41(12):1313-1318.
34. Kurreeman F.A., Daha N.A., Chang M., Catanese J.J., Begovich A.B., Huizinga T.W., et al. Association of IL2RA and IL2RB with rheumatoid arthritis: a replication study in a Dutch population. Ann. Rheum. Dis. 2009 Nov, 68(11):1789-1790.
35. Gregersen P.K., Amos C.I., Lee A.T., Lu Y., Remmers E.F., Kastner D.L., et al. REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis. Nat. Genet. 2009 Jul, 41(7):820-823.
36. Raychaudhuri S., Remmers E.F., Lee A.T., Hackett R., Guiducci C., Burtt N.P., et al. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat. Genet. 2008 Oct, 40(10):1216-1223.
37. Plenge R.M., Cotsapas C., Davies L., Price A.L., de Bakker P.I., Maller J., et al. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat. Genet. 2007 Dec, 39(12):1477-1482.
38. Kurreeman F.A., Padyukov L., Marques R.B., Schrodi S.J., Seddighzadeh M., Stoeken-Rijsbergen G., et al. A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis. PLoS Med. 2007 Sep, 4(9):e278.
39. Remmers E.F., Plenge R.M., Lee A.T., Graham R.R., Hom G., Behrens T.W., et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N. Engl. J. Med. 2007 Sep 6, 357(10):977-986.
40. Plenge R.M., Seielstad M., Padyukov L., Lee A.T., Remmers E.F., Ding B., et al. TRAF1-C5 as a risk locus for rheumatoid arthritis-a genomewide study. N. Engl. J. Med. 2007 Sep 20, 357(12):1199-1209.
41. Karlson E.W., Chibnik L.B., Cui J., Plenge R.M., Glass R.J., Maher N.E., et al. Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study. Ann. Rheum. Dis. 2008 Mar, 67(3):358-363.
42. Plenge R.M., Padyukov L., Remmers E.F., Purcell S., Lee A.T., Karlson E.W., et al. Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am. J. Hum. Genet. 2005 Dec, 77(6):1044-1060.
43. Stahl E.A., Wegmann D., Trynka G., Gutierrez-Achury J., Do R., Voight B.F., et al. Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis. Nat. Genet. 2012 May, 44(5):483-489.
44. Cloutier J.F., Veillette A. Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J. Exp. Med. 1999 Jan 4, 189(1):111-121.
45. Rieck M., Arechiga A., Onengut-Gumuscu S., Greenbaum C., Concannon P., Buckner J.H. Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. J. Immunol. 2007 Oct 1, 179(7):4704-4710.
46. Rawlings D.J., Dai X., Buckner J.H. The role of PTPN22 risk variant in the development of autoimmunity: finding common ground between mouse and human. J. Immunol. 2015 Apr 1, 194(7):2977-2984.
47. Burn G.L., Svensson L., Sanchez-Blanco C., Saini M., Cope A.P. Why is PTPN22 a good candidate susceptibility gene for autoimmune disease?. FEBS Lett. 2011 Dec 1, 585(23):3689-3698.
48. Zhang J., Zahir N., Jiang Q., Miliotis H., Heyraud S., Meng X., et al. The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness. Nat. Genet. 2011 Sep, 43(9):902-907.
49. Suzuki A., Yamada R., Chang X., Tokuhiro S., Sawada T., Suzuki M., et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat. Genet. 2003 Aug, 34(4):395-402.
50. Huizinga T.W., Amos C.I., van der Helm-van Mil A.H., Chen W., van Gaalen F.A., Jawaheer D., et al. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum. 2005 Nov, 52(11):3433-3438.
51. Brinkmann V., Reichard U., Goosmann C., Fauler B., Uhlemann Y., Weiss D.S., et al. Neutrophil extracellular traps kill bacteria. Science 2004 Mar 5, 303(5663):1532-1535.
52. Chang H.H., Dwivedi N., Nicholas A.P., Ho I.C. The W620 polymorphism of PTPN22 disrupts its interaction with PAD4 and enhances citrullination and NETosis. Arthritis Rheumatol. 2015 May 27, (Epub ahead of print), pubmed ID:. http://www.ncbi.nlm.nih.gov/pubmed/26019128, 10.1002/art.39215.
53. Adrianto I., Wen F., Templeton A., Wiley G., King J.B., Lessard C.J., et al. Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus. Nat. Genet. 2011 Mar, 43(3):253-258.
54. Ferreira R.C., Freitag D.F., Cutler A.J., Howson J.M., Rainbow D.B., Smyth D.J., et al. Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseases. PLoS Genet. 2013 Apr, 9(4):e1003444.
55. Myouzen K., Kochi Y., Okada Y., Terao C., Suzuki A., Ikari K., et al. Functional variants in NFKBIE and RTKN2 involved in activation of the NF-kappaB pathway are associated with rheumatoid arthritis in Japanese. PLoS Genet. 2012 Sep, 8(9):e1002949.
56. Cenit M.C., Martinez-Florensa M., Consuegra M., Bonet L., Carnero-Montoro E., Armiger N., et al. Analysis of ancestral and functionally relevant CD5 variants in systemic lupus erythematosus patients. PLoS One 2014, 9(11):e113090.
57. Li G., Diogo D., Wu D., Spoonamore J., Dancik V., Franke L., et al. Human genetics in rheumatoid arthritis guides a high-throughput drug screen of the CD40 signaling pathway. PLoS Genet. 2013 May, 9(5):e1003487.
58. Haas J.D., Gonzalez F.H., Schmitz S., Chennupati V., Fohse L., Kremmer E., et al. CCR6 and NK1.1 distinguish between IL-17A and IFN-gamma-producing gammadelta effector T cells. Eur. J. Immunol. 2009 Dec, 39(12):3488-3497.
59. Kochi Y., Okada Y., Suzuki A., Ikari K., Terao C., Takahashi A., et al. A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility. Nat. Genet. 2010 Jun, 42(6):515-519.
60. van Hamburg J.P., Asmawidjaja P.S., Davelaar N., Mus A.M., Colin E.M., Hazes J.M., et al. Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production. Arthritis Rheum. 2011 Jan, 63(1):73-83.
61. Song H.Y., Rothe M., Goeddel D.V. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation. Proc. Natl. Acad. Sci. U. S. A. 1996 Jun 25, 93(13):6721-6725.
62. Orozco G., Hinks A., Eyre S., Ke X., Gibbons L.J., Bowes J., et al. Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23. Hum. Mol. Genet. 2009 Jul 15, 18(14):2693-2699.
63. Matmati M., Jacques P., Maelfait J., Verheugen E., Kool M., Sze M., et al. A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis. Nat. Genet. 2011 Sep, 43(9):908-912.
64. Dendrou C.A., Plagnol V., Fung E., Yang J.H., Downes K., Cooper J.D., et al. Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource. Nat. Genet. 2009 Sep, 41(9):1011-1015.
65. Raychaudhuri S., Plenge R.M., Rossin E.J., Ng A.C., Purcell S.M., Sklar P., et al. Identifying relationships among genomic disease regions: predicting genes at pathogenic SNP associations and rare deletions. PLoS Genet. 2009 Jun, 5(6):e1000534.
66. Pers T.H., Karjalainen J.M., Chan Y., Westra H.J., Wood A.R., Yang J., et al. Biological interpretation of genome-wide association studies using predicted gene functions. Nat. Commun. 2015, 6:5890.
67. Szklarczyk D., Franceschini A., Wyder S., Forslund K., Heller D., Huerta-Cepas J., et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015 Jan, 43(Database issue):D447-D452.
68. Garber K. Pfizer's JAK inhibitor sails through phase 3 in rheumatoid arthritis. Nat. Biotechnol. 2011 Jun, 29(6):467-468.
69. Nishimura K., Saegusa J., Matsuki F., Akashi K., Kageyama G., Morinobu A. Tofacitinib facilitates the expansion of myeloid-derived suppressor cells and ameliorates arthritis in SKG mice. Arthritis Rheumatol. 2015 Apr, 67(4):893-902.
70. Boyle D.L., Soma K., Hodge J., Kavanaugh A., Mandel D., Mease P., et al. The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis. Ann. Rheum. Dis. 2015 Jun, 74(6):1311-1316.
71. Garber K. Pfizer's first-in-class JAK inhibitor pricey for rheumatoid arthritis market. Nat. Biotechnol. 2013 Jan, 31(1):3-4.
72. Gusev A., Lee S.H., Trynka G., Finucane H., Vilhjalmsson B.J., Xu H., et al. Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases. Am. J. Hum. Genet. 2014 Nov 6, 95(5):535-552.
73. Nicolae D.L., Gamazon E., Zhang W., Duan S., Dolan M.E., Cox N.J. Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet. 2010 Apr, 6(4):e1000888.
74. Nica A.C., Montgomery S.B., Dimas A.S., Stranger B.E., Beazley C., Barroso I., et al. Candidate causal regulatory effects by integration of expression QTLs with complex trait genetic associations. PLoS Genet. 2010 Apr, 6(4):e1000895.
75. Westra H.J., Peters M.J., Esko T., Yaghootkar H., Schurmann C., Kettunen J., et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat. Genet. 2013 Oct, 45(10):1238-1243.
76. Dubois P.C., Trynka G., Franke L., Hunt K.A., Romanos J., Curtotti A., et al. Multiple common variants for celiac disease influencing immune gene expression. Nat. Genet. 2010 Apr, 42(4):295-302.
77. Hu X., Kim H., Raj T., Brennan P.J., Trynka G., Teslovich N., et al. Regulation of gene expression in autoimmune disease loci and the genetic basis of proliferation in CD4+ effector memory T cells. PLoS Genet. 2014 Jun, 10(6):e1004404.
78. Hu X., Kim H., Stahl E., Plenge R., Daly M., Raychaudhuri S. Integrating autoimmune risk loci with gene-expression data identifies specific pathogenic immune cell subsets. Am. J. Hum. Genet. 2011 Oct 7, 89(4):496-506.
79. Raj T., Rothamel K., Mostafavi S., Ye C., Lee M.N., Replogle J.M., et al. Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytes. Science 2014 May 2, 344(6183):519-523.
80. Kim S., Becker J., Bechheim M., Kaiser V., Noursadeghi M., Fricker N., et al. Characterizing the genetic basis of innate immune response in TLR4-activated human monocytes. Nat. Commun. 2014, 5:5236.
81. Rotival M., Zeller T., Wild P.S., Maouche S., Szymczak S., Schillert A., et al. Integrating genome-wide genetic variations and monocyte expression data reveals trans-regulated gene modules in humans. PLoS Genet. 2011 Dec, 7(12):e1002367.
82. Franke L., Jansen R.C. eQTL analysis in humans. Methods Mol. Biol. 2009, 573:311-328.
83. Westra H.J., Arends D., Esko T., Peters M.J., Schurmann C., Schramm K., et al. Cell Specific eQTL Analysis without Sorting Cells. PLoS Genet. 2015 May, 11(5):e1005223.
84. Fairfax B.P., Knight J.C. Genetics of gene expression in immunity to infection. Curr. Opin. Immunol. 2014 Oct, 30:63-71.
85. Fairfax B.P., Humburg P., Makino S., Naranbhai V., Wong D., Lau E., et al. Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression. Science 2014 Mar 7, 343(6175):1246949.
86. De Jager P.L., Hacohen N., Mathis D., Regev A., Stranger B.E., Benoist C. ImmVar project: Insights and design considerations for future studies of "healthy" immune variation. Semin. Immunol. 2015 Feb, 27(1):51-57.
87. Lee M.N., Ye C., Villani A.C., Raj T., Li W., Eisenhaure T.M., et al. Common genetic variants modulate pathogen-sensing responses in human dendritic cells. Science 2014 Mar 7, 343(6175):1246980.
88. Pickrell J.K., Marioni J.C., Pai A.A., Degner J.F., Engelhardt B.E., Nkadori E., et al. Understanding mechanisms underlying human gene expression variation with RNA sequencing. Nature 2010 Apr 1, 464(7289):768-772.
89. Montgomery S.B., Sammeth M., Gutierrez-Arcelus M., Lach R.P., Ingle C., Nisbett J., et al. Transcriptome genetics using second generation sequencing in a Caucasian population. Nature 2010 Apr 1, 464(7289):773-777.
90. Trynka G., Raychaudhuri S. Using chromatin marks to interpret and localize genetic associations to complex human traits and diseases. Curr. Opin. Genet. Dev. 2013 Dec, 23(6):635-641.
91. Trynka G., Sandor C., Han B., Xu H., Stranger B.E., Liu X.S., et al. Chromatin marks identify critical cell types for fine mapping complex trait variants. Nat. Genet. 2013 Feb, 45(2):124-130.
92. An integrated encyclopedia of DNA elements in the human genome. Nature 2012 Sep 6, 489(7414):57-74.
93. Maurano M.T., Humbert R., Rynes E., Thurman R.E., Haugen E., Wang H., et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 2012 Sep 7, 337(6099):1190-1195.
94. Thurman R.E., Rynes E., Humbert R., Vierstra J., Maurano M.T., Haugen E., et al. The accessible chromatin landscape of the human genome. Nature 2012 Sep 6, 489(7414):75-82.
95. Vahedi G., Kanno Y., Furumoto Y., Jiang K., Parker S.C., Erdos M.R., et al. Super-enhancers delineate disease-associated regulatory nodes in T cells. Nature 2015 Apr 23, 520(7548):558-562.
96. Hnisz D., Abraham B.J., Lee T.I., Lau A., Saint-Andre V., Sigova A.A., et al. Super-enhancers in the control of cell identity and disease. Cell 2013 Nov 7, 155(4):934-947.
97. Farh K.K., Marson A., Zhu J., Kleinewietfeld M., Housley W.J., Beik S., et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 2015 Feb 19, 518(7539):337-343.
98. Ernst J., Kheradpour P., Mikkelsen T.S., Shoresh N., Ward L.D., Epstein C.B., et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 2011 May 5, 473(7345):43-49.
99. Kundaje A., Meuleman W., Ernst J., Bilenky M., Yen A., Heravi-Moussavi A., et al. Integrative analysis of 111 reference human epigenomes. Nature 2015 Feb 19, 518(7539):317-330.
100. Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., et al. The transcriptional landscape of the mammalian genome. Science 2005 Sep 2, 309(5740):1559-1563.
101. Birney E., Stamatoyannopoulos J.A., Dutta A., Guigo R., Gingeras T.R., Margulies E.H., et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007 Jun 14, 447(7146):799-816.
102. Bu D., Yu K., Sun S., Xie C., Skogerbo G., Miao R., et al. NONCODE v3.0: integrative annotation of long noncoding RNAs. Nucleic Acids Res. 2012 Jan, 40(Database issue):D210-D215.
103. Bhartiya D., Pal K., Ghosh S., Kapoor S., Jalali S., Panwar B., et al. lncRNome: a comprehensive knowledgebase of human long noncoding RNAs. Database (Oxford) 2013, 2013:bat034.
104. Wilusz J.E., Sunwoo H., Spector D.L. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev. 2009 Jul 1, 23(13):1494-1504.
105. Zhao J., Sun B.K., Erwin J.A., Song J.J., Lee J.T. Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science 2008 Oct 31, 322(5902):750-756.
106. Mercer T.R., Dinger M.E., Mattick J.S. Long non-coding RNAs: insights into functions. Nat. Rev. Genet. 2009 Mar, 10(3):155-159.
107. Wang K.C., Chang H.Y. Molecular mechanisms of long noncoding RNAs. Mol. Cell 2011 Sep 16, 43(6):904-914.
108. Li J., Xuan Z., Liu C. Long non-coding RNAs and complex human diseases. Int. J. Mol. Sci. 2013, 14(9):18790-18808.
109. Gupta B., Hawkins R.D. Epigenomics of autoimmune diseases. Immunol. Cell Biol. 2015 Mar, 93(3):271-276.
110. Gutschner T., Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012 Jun, 9(6):703-719.
111. Carpenter S., Aiello D., Atianand M.K., Ricci E.P., Gandhi P., Hall L.L., et al. A long noncoding RNA mediates both activation and repression of immune response genes. Science 2013 Aug 16, 341(6147):789-792.
112. Ding J., Eyre S., Worthington J. Genetics of RA susceptibility, what comes next?. RMD Open 2015, 1. e000028-e000028. 10.1136/rmdopen-2014-000028.
113. Cui H., Xie N., Tan Z., Banerjee S., Thannickal V.J., Abraham E., et al. The human long noncoding RNA lnc-IL7R regulates the inflammatory response. Eur. J. Immunol. 2014 Jul, 44(7):2085-2095.
114. Mao A.P., Shen J., Zuo Z. Expression and regulation of long noncoding RNAs in TLR4 signaling in mouse macrophages. BMC Genomics 2015, 16:45.
115. Muller N., Doring F., Klapper M., Neumann K., Schulte D.M., Turk K., et al. Interleukin-6 and tumour necrosis factor-alpha differentially regulate lincRNA transcripts in cells of the innate immune system in vivo in human subjects with rheumatoid arthritis. Cytokine 2014 Jul, 68(1):65-68.
116. Kumar V., Westra H.J., Karjalainen J., Zhernakova D.V., Esko T., Hrdlickova B., et al. Human disease-associated genetic variation impacts large intergenic non-coding RNA expression. PLoS Genet. 2013, 9(1):e1003201.
117. Jensen L.J., Kuhn M., Stark M., Chaffron S., Creevey C., Muller J., et al. STRING 8-a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res. 2009 Jan, 37(Database issue):D412-D416.
118. Warde-Farley D., Donaldson S.L., Comes O., Zuberi K., Badrawi R., Chao P., et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010 Jul, 38(Web Server issue):W214-W220.